Xtant Medical Holdings Investor Relations Material
Latest events
Q3 2023
Xtant Medical Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Xtant Medical Holdings Inc
Access all reports
Xtant Medical Holdings Inc develops and manufactures regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The Company's OsteoSponge biomaterial is a natural scaffold used to promote bone formation or repair. Its other products include OsteoStop, an autologous cell therapy that induces a pro-inflammatory response to reduce endothelial cell activation, OsteoSelect DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor cream that contains various proteins and peptides that support bone formation and remodeling.
Key slides for Xtant Medical Holdings Inc
Investor Presentation
Xtant Medical Holdings Inc
Investor Presentation
Xtant Medical Holdings Inc
Latest articles
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
John Elkann: Leading Stellantis, Ferrari, and Exor to New Heights
As the Chairman of Stellantis and Ferrari and CEO of Exor, John Elkann is arguably the most influential person in the global automotive sector.
26 Mar 2024
Ticker symbol
Country
🇺🇸 United States